-
41
A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine
Published 2022-09-01Get full text
Article -
42
Efficacy of Pfizer vaccine on IL-12/IFN-γ pathway with related to COVID-19 infection
Published 2023-01-01“…However, this study design to evaluate effectiveness of Pfizer vaccine on serum level for IL-12/IFN-γ pathway with susceptibility to COVID-19. …”
Get full text
Article -
43
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
Published 2022-01-01Subjects: Get full text
Article -
44
Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine
Published 2022-03-01Get full text
Article -
45
Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia
Published 2022-09-01Subjects: Get full text
Article -
46
Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program
Published 2007-03-01“…From 2003 to 2005, the Pfizer Global Health Fellows program sent 72 employees to work with organizations in 19 countries. …”
Get full text
Article -
47
6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers
Published 2022-01-01“…<h4>Aim</h4> Healthcare workers (HCWs) were among the first group of people vaccinated with the Pfizer-BioNTech Covid-19 vaccine (BNT162b2). Characterization of the kinetics of antibody response to vaccination is important to devise future vaccination strategies. …”
Get full text
Article -
48
Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department
Published 2023-08-01“…Background: Cardiovascular complications after Pfizer–BioNTech COVID-19 (BNT) vaccination are a concern, especially in adolescents. …”
Get full text
Article -
49
Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine
Published 2022-07-01Subjects: Get full text
Article -
50
Role of Purine-Rich Regions in Mason-Pfizer Monkey Virus (MPMV) Genomic RNA Packaging and Propagation
Published 2020-11-01Subjects: “…Mason-Pfizer monkey virus…”
Get full text
Article -
51
Mason-Pfizer Monkey Virus Envelope Glycoprotein Cycling and Its Vesicular Co-Transport with Immature Particles
Published 2018-10-01Subjects: “…Mason-Pfizer monkey virus…”
Get full text
Article -
52
6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
Published 2022-01-01“…<h4>Aim</h4>Healthcare workers (HCWs) were among the first group of people vaccinated with the Pfizer-BioNTech Covid-19 vaccine (BNT162b2). Characterization of the kinetics of antibody response to vaccination is important to devise future vaccination strategies. …”
Get full text
Article -
53
Bibliometric Analysis of Pfizer-BioNTech (BNT162B2): A COVID-19 Vaccine
Published 2021-09-01Subjects: Get full text
Article -
54
A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia
Published 2022-08-01“…Abstract The Pfizer COVID-19 vaccine is associated with increased myocarditis incidence. …”
Get full text
Article -
55
Clinical outcomes of Pfizer‐BioNTech COVID‐19 vaccine in children and adolescents: A systematic review
Published 2022-07-01Subjects: Get full text
Article -
56
Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
Published 2021-12-01“…Objective: To evaluate the safety and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in gynecologic oncology patients under chemotherapy. …”
Get full text
Article -
57
Administration of an excessive dosage of covid-19 pfizer vaccine in an infant: Case report of clinical and immune responses
Published 2023-12-01“…Introduction/Case report: We describe the case of a 6-month-old female infant who received the equivalent of 6 adult doses of the COVID-19 Pfizer vaccine due to an immunization error. The patient underwent clinical and laboratory evaluations from the time of vaccination error (January 2022) until November 2022. …”
Get full text
Article -
58
A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination
Published 2022-01-01“…We present a case of an 81-year-old male evaluated in the emergency department for a bilateral purpuric non-blanching rash that appeared ten days after receiving the Pfizer-BioNTech booster vaccine against SARS-CoV-2. …”
Get full text
Article -
59
Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA Vaccination
Published 2022-06-01Get full text
Article -
60
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
Published 2023-08-01Get full text
Article